Stockscreener 앱 받기
1.60
0.00%
0.00
Essa Pharma Inc 주식(EPIX)의 최신 뉴스
Surprising News! ESSA Pharma’s Big Breakthrough Expected Soon. - Jomfruland.net
When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit? - Yahoo Finance
ESSA Pharma’s Cash Management: A Potential Risk to Shareholder Value and Market Stability - TipRanks
ESSA Pharma Inc. Reports Strategic Shift Amid Losses - TipRanks
ESSA Pharma: Fiscal Q4 Earnings Snapshot - The Ridgefield Press
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 - Barchart
ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024 - Marketscreener.com
ESSA Pharma (NASDAQ:EPIX) Issues Quarterly Earnings Results - MarketBeat
SEC Form 10-K filed by ESSA Pharma Inc. - Quantisnow
ESSA Pharma Halts Key Cancer Drug Trials, Initiates Strategic Review Amid Clinical Setback - StockTitan
ESSA Pharma ends long-standing license agreement with cancer agencies - Investing.com
ESSA Pharma Inc. Adopts Executive Severance Plan**United States Securities and Exchange Commission Filing – ESSA Pharma Inc. submitted a current report on Form 8-K, dated June 5, 2024, announcing the adoption of the ESSA Pharma Inc. Severance P - Defense World
ESSA Pharma Introduces New Executive Severance Plan - TipRanks
RTW Investments LP Grows Stake in ESSA Pharma Inc. (NASDAQ:EPIX) - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc.EPIX - PR Newswire
Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session - MSN
Piper Sandler Downgrades ESSA Pharma (EPIX) - MSN
United States shares higher at close of trade; Dow Jones Industrial Average up 0.69% - MSN
Thinking about buying stock in Adverum Biotechnologies, Roma Gre - GuruFocus.com
Oppenheimer Downgrades ESSA Pharma (EPIX) - MSN
PFM Health Sciences, LP Adjusts Stake in ESSA Pharma Inc - GuruFocus.com
RTW INVESTMENTS, LP Acquires Shares in ESSA Pharma Inc - GuruFocus.com
ESSA Pharma (NASDAQ:EPIX) Stock Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
ESSA Pharma And 2 Other US Penny Stocks To Watch - Yahoo Finance
Jones Trading Downgrades ESSA Pharma (EPIX) - MSN
ESSA Pharma (NASDAQ:EPIX) Lowered to Market Perform Rating by Oppenheimer - Defense World
ESSA Pharma (NASDAQ:EPIX) Rating Lowered to Neutral at Piper Sandler - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ESSA Pharma Inc. (EPIX) and Encourages Shareholders to Learn More About the Investigation - AccessWire
Finance Watch: Syndax Raises $350m, KalVista Gets $100m In Royalty Deals - Citeline News & Insights
Growth N. V. Biotech Sells 7,879,583 Shares of ESSA Pharma Inc. (NASDAQ:EPIX) Stock - MarketBeat
Bb biotech ag sells Essa Pharma shares for $12 million - Investing.com
Bb biotech ag sells Essa Pharma shares for $12 million By Investing.com - Investing.com UK
ESSA Pharma Inc. (EPIX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
ESSA Pharma shares downgraded after halting drug development By Investing.com - Investing.com Canada
ESSA Pharma terminates vital trial, leading Piper Sandler to cut shares rating - Investing.com Canada
ESSA Pharma downgraded by Oppenheimer, Piper Sandler after drug setback in trials - Investing.com Canada
Jefferies Financial Group Downgrades ESSA Pharma (NASDAQ:EPIX) to Hold - MarketBeat
2024-11-03 | Bronstein, Gewirtz & Grossman, LLC Is Investigating ESSA Pharma Inc. (EPIX) And Encourages Stockholders to Connect | NDAQ:EPIX | Press Release - Stockhouse Publishing
Michael Jenson, PA-C, on Minnesota Urology’s Surgical Impotence Management Strategy program - Urology Times
Bronstein, Gewirtz & Grossman, LLC Is Investigating ESSA Pharma Inc. (EPIX) And Encourages Stockholders to Connect - AccessWire
ESSA Pharma tank as it drops Phase II masofaniten study - The Pharma Letter
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.69% - MSN
ESSA Pharma stock plunges to 52-week low of $1.55 - Investing.com India
ESSA Pharma stock plunges to 52-week low of $1.55 By Investing.com - Investing.com South Africa
ESSA Pharma Inc. (EPIX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.69% - Investing.com
Essa ends prostate cancer bid, seeks strategic options - BioWorld Online
ESSA Pharma tanks after terminating trial for its prostate cancer treatment - MSN
Crude Oil Moves Higher; Apple Shares Slide After Q4 Results - Benzinga
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results - Benzinga
ESSA Discontinues Phase 2 Study of Masofaniten Plus Enzalutamide in mCRPC - OncLive
2.88%
2.65%
자본화:
|
볼륨(24시간):